نتایج جستجو برای: cytotoxic therapy

تعداد نتایج: 702526  

Journal: :Science translational medicine 2015
James D Byrne Mohammad R N Jajja Adrian T O'Neill Lissett R Bickford Amanda W Keeler Nabeel Hyder Kyle Wagner Allison Deal Ryan E Little Richard A Moffitt Colleen Stack Meredith Nelson Christopher R Brooks William Lee J Chris Luft Mary E Napier David Darr Carey K Anders Richard Stack Joel E Tepper Andrew Z Wang William C Zamboni Jen Jen Yeh Joseph M DeSimone

Parenteral and oral routes have been the traditional methods of administering cytotoxic agents to cancer patients. Unfortunately, the maximum potential effect of these cytotoxic agents has been limited because of systemic toxicity and poor tumor perfusion. In an attempt to improve the efficacy of cytotoxic agents while mitigating their side effects, we have developed modalities for the localize...

2014
Paul W. Denton Julie M. Long Stephen W. Wietgrefe Craig Sykes Rae Ann Spagnuolo Olivia D. Snyder Katherine Perkey Nancie M. Archin Shailesh K. Choudhary Kuo Yang Michael G. Hudgens Ira Pastan Ashley T. Haase Angela D. Kashuba Edward A. Berger David M. Margolis J. Victor Garcia

Antiretroviral therapy (ART) can reduce HIV levels in plasma to undetectable levels, but rather little is known about the effects of ART outside of the peripheral blood regarding persistent virus production in tissue reservoirs. Understanding the dynamics of ART-induced reductions in viral RNA (vRNA) levels throughout the body is important for the development of strategies to eradicate infectio...

Journal: :Kidney cancer 2021

Sarcomatoid renal cell carcinoma (sRCC) is an aggressive form of kidney cancer that associated with poor prognosis. It can arise from any histologic type carcinoma. The majority cases will present advanced or metastatic disease requiring systemic therapy. Nephrectomy the treatment choice in locally resectable disease. therapeutic options for sRCC have evolved past decade. Cytotoxic chemotherapy...

Fatemeh Pourrajab , Parisa i Yazdani Elahabad, Seyedhossein Hekmatimoghaddam ,

Natural killer (NK) cells are effector cells of the innate immune system that exert direct cytotoxic functions. Ubiquitously-expressed toll-like receptors (TLRs) have been recognized as one of the major components promoting dendritic cell (DC) maturation, which may induce polarized immune responses beneficial to cancer immunotherapy. TLR-activated NK cells and DCs are prerequisite for robust ac...

Introduction: For thousands of years, plants have been used as the main source of drug worldwide. Recently, it has been found out that the plant Artemisia annua and especially its derivatives such as artemether have anticancer properties. Methods: In this study, the anticancer effect of artemether on MCF-7 breast cancer cell line was examined. MTT assay was used to assess the viability of c...

Journal: :Cancer control : journal of the Moffitt Cancer Center 2013
James C Marsh Justin Goldfarb Timothy D Shafman Aidnag Z Diaz

BACKGROUND Despite improvements in surgical technique, radiation therapy delivery, and options for systemic cytotoxic therapy, the median survival for patients with newly diagnosed glioblastoma multiforme remains poor at 15 months with trimodality therapy. Multiple immunologic approaches are being tested to enhance the response of these tumors to existing therapy and/or to stimulate innate immu...

2017
Irina Kareva

Therapeutic resistance remains a major obstacle in treating many cancers, particularly in advanced stages. It is likely that cytotoxic lymphocytes (CTLs) have the potential to eliminate therapy-resistant cancer cells. However, their effectiveness may be limited either by the immunosuppressive tumor microenvironment, or by immune cell death induced by cytotoxic treatments. High-frequency low-dos...

2000
M. P. Napier S. K. Sharma C. J. Springer K. D. Bagshawe A. J. Green J. Martin S. M. Stribbling N. Cushen R. H. J. Begent

In antibody-directed enzyme prodrug therapy, an enzyme conjugated to an antitumor antibody is given i.v. and localizes in the tumor. A prodrug is then given, which is converted to a cytotoxic drug selectively in the tumor. Ten patients with colorectal carcinoma expressing carcinoembryonic antigen received antibody-directed enzyme prodrug therapy with A5B7 F(ab*)2 antibody to carcinoembryonic an...

2012
Masashi Kanai Sushovan Guha Bharat B. Aggarwal

Gemcitabine has been the standard chemotherapy for advanced pancreatic cancer since 1997, when a randomized phase III study demonstrated that gemcitabine significantly improved cancer-related symptoms in comparison with 5-fluorouracil (5-FU) (Burris et al., 1997). However, the survival benefit of gemcitabine is modest and the median survival time was 5.7 and 4.4 months for gemcitabine and 5-FU ...

2017
Min Lu Amelia S Zessin Wayne Glover David S Hsu

BACKGROUND Standard of care treatment for colorectal cancer liver metastasis consists of a cytotoxic chemotherapy in combination with a targeted agent. Clinical trials have guided the use of these combinatory therapies, but it remains unclear what the optimal combinations of cytotoxic chemotherapy with a targeted agent are. METHODS Using a genomic based approach, gene expression profiling was...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید